Roche to shed 170 jobs in diagnostics restructuring

Roche ($RHHBY) plans to cut 170 jobs in the U.S. and Germany as it winds down the applied sciences business in its lagging diagnostics division. Report

Suggested Articles

Pharma companies filed suit Friday to block the new HHS rule that requires drugmakers to put list prices in TV ads.

Cannes Lions Health kicks off Monday, and attendees are looking for some breakouts—leading-edge tech, creativity and inspiration, for instance.

Bluebird has priced gene therapy Zynteglo at €1.575 million in Europe and promised a U.S. price in “reasonably close” range.